SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novavax NVAX
NVAX 8.400-0.4%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (157)12/15/2022 5:47:27 PM
From: Paul Senior  Read Replies (1) of 166
 
Poor NVAX. I've been out of it for a while, but still... poor me. One of my worst investments.

"Novavax Tumbles on Cut to UK Covid Vaccine-Supply Deal, Capital Raising"

Today down about $6 to $11. Yikes. Well you get this -- "I wouldn't have believed it, if I hadn't seen it" scenario - every once in a while. Shocking.

finance.yahoo.com

Company seems to have been the "betamax" of Covid shots. Great product. Poor execution, imo

Otoh, what a wonderful company to have shorted anytime in 2022. Missed that too. I just couldn't see that, couldn't bring myself to it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext